Table of Contents
What changed
Revenue fell 5.3% to $81.1m as unit settlements dropped from 158 to 90 (–43%), with the revenue decline cushioned by higher average revenue per unit and a step-up in commercial portfolio revenue. EBITDA collapsed from $14.2m to a $0.1m loss, PBT swung from $13.6m to –$2.4m, and NPAT moved from $9.7m profit to a $2.0m loss. Despite the P&L reversal, operating cash flow improved 55.3% to $27.1m. The balance sheet, however, moved decisively: cash fell from $99.3m to $26.1m, gross borrowings rose 23.9% to $79.4m, and the group moved from $35.2m of net cash at HY24 to $53.3m of net debt at HY25. Segment mix shifted – residential development fell from 96.8% to 87.1% of revenue while commercial portfolio scaled from 3.2% to 12.8%. No interim dividend was declared (HY24: 0.55 cents per share).
What matters
- Operating margin has thinned materially in the core segment. Residential development, still the dominant profit engine, saw its implied EBIT margin compress from roughly 20.9% to 8.8%. With settlements running well below HY24, the fixed-cost base is more visible and less able to be absorbed.
- The balance sheet flipped from net cash to net debt in twelve months. A $73.2m cash drawdown and a $15.3m increase in gross borrowings reflect continued deployment into the commercial portfolio and retirement villages – both of which remain loss-making (–$4.7m and –$1.7m at segment result level respectively) while residential earnings weakened.
- Capital allocation is now investment-heavy. Capex rose to $46.9m (57.9% of revenue) from $24.4m (28.5%), producing pre-lease free cash flow of –$19.9m versus –$7.0m in HY24. The absence of an interim dividend is consistent with this posture, but is a clear change from HY24.
Expectations
No quantitative forward-work target or formal earnings guidance was disclosed, so forward run-rate discipline has to be inferred. Using HY24 seasonality as the only available shape context, HY24 contributed 49.3% of FY24 revenue, 48% of EBITDA and 61.8% of NPAT – i.e. the prior year was slightly second-half weighted at the revenue and EBITDA lines and meaningfully second-half weighted at NPAT. Applied naively to HY25, that shape implies a second-half skew is needed just to match FY24 EBITDA of $29.5m, which looks demanding given HY25 EBITDA is effectively zero. Annualised HY25 revenue of $162.1m sits about $11.5m below the FY24 anchor of $173.6m. The release does not support any firmer statement than that the current run-rate is tracking below FY24 and is reliant on a pronounced H2 recovery in settlements.
Quality of result
The headline operating cash inflow of $27.1m looks strong in isolation but is primarily inventory-driven: inventories fell 7.4% ($17.4m) as settlements released working capital, while EBITDA was negligible. The tax line also masked the underlying deterioration – a $0.4m tax benefit on the pre-tax loss narrowed the reported NPAT gap, which is why PBT (–117.9%) is the cleaner read on operating performance than NPAT (–120.6%). Cash conversion relative to earnings is not meaningful given negative EBITDA, but the combination of an inventory-release-led cash inflow, sharply higher capex and a $73.2m cash drawdown indicates the period's apparent cash strength is not durable in its current form. The segment-level picture – a weaker core and two scaling loss-makers – reinforces that the result is more cyclically pressured than one-off in nature.
Unresolved
- What is the pre-sale pipeline and settlement phasing for H2 FY25, and does it support a return to FY24-style EBITDA?
- When are the commercial portfolio and retirement villages expected to reach contribution break-even, and how much further capex is committed before then?
- What is the available headroom on the MMLIC and MCCB facilities, and what covenants apply given the move into net debt?
- What is the board's dividend policy going forward, given no interim was declared this half?
- Why were receivables and payables not separately disclosed, and what is underlying trade debtor quality?
This briefing cannot assess unit-level pre-sale coverage, facility covenant headroom, or the valuation implications of the balance-sheet shift, as NTA per share and forward-work metrics were not disclosed.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $81.1m | $85.6m | -5.3% ↓ |
| EBITDA | −$0.06m | $14.2m | -100.4% ↓ |
| Net profit after tax | −$2m | $9.7m | -120.6% ↓ |
| Net cash inflow from operating activities | $27.1m | $17.4m | +55.3% ↑ |
| Declared dividend per share | — | 0.5c | — |
| Operating profit | −$2.3m | $13m | -117.6% ↓ |
| Profit before tax | −$2.4m | $13.6m | -117.9% ↓ |
| Cash and cash equivalents | $26.1m | $99.3m | -73.7% ↓ |
| Total assets | $663.3m | $648.1m | +2.3% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Residential development | $70.6m | $82.9m | $6.2m | -9.7pp |
| Retirement villages | $0.02m | — | −$1.7m | n/a |
| Commercial portfolio | $10.4m | $2.7m | −$4.7m | +9.6pp |
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | -28.2% | current loss period |
| OCF / EBITDA (cash conversion) | n/m | 122.9% | deteriorated |
| FCF pre-lease | −$19.9m | −$7m | −$12.9m |
| FCF / NPAT | 992.8% | -72.0% | complementary conversion metric |
| Capex % revenue | 57.9% | 28.5% | — |
| Capex | $46.9m | $24.4m | +$22.5m |
| Net debt | $53.3m | −$35.2m | +$88.5m |
| Net debt / EBITDA | -951.80x | -2.50x | Weakening |
| Gross borrowings | $79.4m | $64.1m | +$15.3m |
| ROE (annualised) | -0.4% | 1.9% | Weakening |
| HY24 share of FY24 revenue | 49.3% | — | Other half was 50.7% |
| HY24 share of FY24 EBITDA | 48.0% | — | Other half was 52.0% |
| HY24 share of FY24 NPAT | 61.8% | — | Other half was 38.2% |
| Profit from continuing operations | −$2m | $9.7m | −$11.7m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.